ArticleChild's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery2015

A phase I trial and PK study of cediranib (AZD2171), an orally bioavailable pan-VEGFR inhibitor, in children with recurrent or refractory primary CNS tumors.

Mark W Kieran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.